Screener / SEC EDGAR /CIK 0001773751 /10-K filed Feb 23, 2026, compared with Feb 24, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Offices & Clinics of Doctors of Medicine

Hims & Hers Health, Inc. HIMS

Compare with peers Embed
Planned sales, announced before they happen

3 trading plans running, 33 Form 144 notices for $18.9M

10-Q, 10-K and Form 144

What HIMS's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Mar 4, 2025 to Sep 8, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Andrew Dudum
Director and Chief Executive Officer
Adopted 10b5-1 plan Sep 1, 2026 10-Q Nov 9, 2026
Irene Becklund
Former Chief Accounting Officer(2)
Ended 10b5-1 plan Aug 12, 2026 10-Q Nov 9, 2026
Soleil Boughton
Chief Legal Officer
Ended 10b5-1 plan May 21, 2026 10-Q Aug 10, 2026
Deborah Autor
Director and Chief Policy Officer
Ended 10b5-1 plan May 20, 2026 10-Q Aug 10, 2026
Oluyemi Okupe
Chief Financial Officer
Adopted 10b5-1 plan May 20, 2026 10-Q Aug 10, 2026
Michael Chi
Chief Operating Officer
Adopted 10b5-1 plan Dec 1, 2025 10-K Feb 23, 2026
Mohamed Elshenawy
Chief Technology Officer
Adopted 10b5-1 plan Dec 1, 2025 10-K Feb 23, 2026
Soleil Boughton
Chief Legal Officer
Adopted 10b5-1 plan Nov 18, 2025 10-K Feb 23, 2026
Andrew Dudum
Chief Executive Officer
Ended 10b5-1 plan Nov 14, 2025 10-K Feb 23, 2026
Patrick H. Carroll, M.D.
Chief Medical Officer and Director
Ended 10b5-1 plan Nov 14, 2025 10-Q Aug 4, 2025
Irene Becklund
Chief Accounting Officer
Adopted 10b5-1 plan Nov 5, 2025 10-K Feb 23, 2026
Deborah Autor
Director
Adopted 10b5-1 plan Aug 11, 2025 10-Q Nov 3, 2025
Oluyemi Okupe
Chief Financial Officer
Adopted 10b5-1 plan May 21, 2025 10-Q Aug 4, 2025
Patrick H. Carroll, M.D.
Chief Medical Officer and Director
Adopted 10b5-1 plan May 19, 2025 10-Q Aug 4, 2025
Mike Chi
Chief Commercial Officer
Adopted 10b5-1 plan Mar 4, 2025 10-Q May 5, 2025
Melissa Baird
Chief Operating Officer
Adopted 10b5-1 plan Nov 26, 2024 10-K Feb 24, 2025
Patrick H. Carroll, M.D.
Chief Medical Officer and Director
Adopted 10b5-1 plan Nov 8, 2024 10-K Feb 24, 2025
Andrew Dudum
Chief Executive Officer
Adopted 10b5-1 plan Aug 28, 2024 10-Q Nov 4, 2024
Soleil Boughton
Chief Legal Officer
Adopted 10b5-1 plan Aug 28, 2024 10-Q Nov 4, 2024
Irene Becklund
SVP, Controller
Adopted 10b5-1 plan Aug 7, 2024 10-Q Nov 4, 2024
Oluyemi Okupe
Chief Financial Officer
Ended 10b5-1 plan May 31, 2024 10-Q Aug 5, 2024
Melissa Baird
Chief Operating Officer
Adopted 10b5-1 plan May 30, 2024 10-Q Aug 5, 2024
Mike Chi
Chief Commercial Officer
Adopted 10b5-1 plan Mar 1, 2024 10-Q May 6, 2024
Michael Chi
Chief Marketing Officer
Ended 10b5-1 plan Dec 15, 2023 10-K Feb 26, 2024
Lynne Chou O’Keefe
Director
Adopted 10b5-1 plan Dec 12, 2023 10-K Feb 26, 2024
Andrew Dudum
Chief Executive Officer
Adopted 10b5-1 plan Nov 29, 2023 10-K Feb 26, 2024
Melissa Baird
Chief Operating Officer
Adopted 10b5-1 plan Nov 21, 2023 10-K Feb 26, 2024
Irene Becklund
SVP, Controller
Adopted 10b5-1 plan Sep 11, 2023 10-Q Nov 6, 2023
Soleil Boughton
CLO
Adopted 10b5-1 plan Sep 8, 2023 10-Q Nov 6, 2023
Lynne Chou O’Keefe, Director
Adopted 10b5-1 plan May 15, 2023 10-Q Aug 7, 2023
Michael Chi, CMO
Adopted 10b5-1 plan May 11, 2023 10-Q Aug 7, 2023
Yemi Okupe, CFO
Ended other arrangement May 10, 2023 10-Q Aug 7, 2023
Melissa Baird
Chief Operating Officer
Adopted plan – 10-Q Aug 5, 2024
Show the other 25 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 8, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Oct 28, 2026 Boughton Soleil
Officer
3,462 $96K
Oct 14, 2026 Boughton Soleil
Officer
3,461 $101K
Oct 1, 2026 Okupe Oluyemi
Officer
2,000 $59K
Sep 30, 2026 Boughton Soleil
Officer
3,461 $101K
Sep 22, 2026 Okupe Oluyemi
Officer
29,277 $877K
Sep 17, 2026 Okupe Oluyemi
Officer
12,313 $355K
Sep 16, 2026 Boughton Soleil
Officer
6,236 $174K
Sep 15, 2026 Elshenawy Mohamed
Officer
7,954 $226K
Sep 15, 2026 Chi Michael
Officer
14,027 $398K
Sep 2, 2026 Boughton Soleil
Officer
3,458 $98K
Aug 19, 2026 Boughton Soleil
Officer
25,111 $692K
Aug 18, 2026 Autor Deborah M.
Officer, Director
16,773 $467K
Jul 22, 2026 Pendarvis Christiane
Former Director
3,500 $113K
Jul 6, 2026 Oluyemi Okupe
Officer
28,652 $1.1M
Jun 18, 2026 Carroll Patrick Harrison
Officer
23,726 $830K
Jun 17, 2026 Becklund Irene
Officer
4,490 $141K
Jun 17, 2026 Elshenawy Mohamed
Officer
30,040 $946K
Jun 17, 2026 Chi Michael
Officer
14,027 $442K
Jun 16, 2026 Becklund Irene
Officer
7,573 $229K
Apr 20, 2026 Boughton Soleil
Officer
9,463 $284K
Apr 6, 2026 Oluyemi Okupe
Officer
240,560 $4.9M
Mar 17, 2026 Boughton Soleil
Officer
4,812 $119K
Mar 17, 2026 Becklund Irene
Officer
5,529 $137K
Mar 17, 2026 Chi Michael
Officer
97,289 $2.4M
Feb 27, 2026 Boughton Soleil
Officer
4,651 $71K
Jan 20, 2026 Oluyemi Okupe
Officer
27,204 $829K
Dec 22, 2025 Oluyemi Okupe
Officer
32,160 $1.1M
Dec 17, 2025 Carroll Patrick Harrison
Officer, Director
10,021 $368K
Dec 17, 2025 Chi Michael
Officer
13,750 $505K
Dec 17, 2025 Becklund Irene
Officer
8,411 $309K
Dec 17, 2025 Autor Deborah M.
Officer, Director
7,054 $259K
Dec 9, 2025 Perez Garcia Andrea G
Director
2,500 $98K
Nov 24, 2025 Boughton Soleil
Officer
2,631 $92K
Show the other 25 notices

From the Form 144 XML filed with the SEC, since Nov 24, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HIMS/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.